Skip to content Skip to footer

Search for Research output

511 - 520 out of 6,707Page size: 10
Sort by: Relevance
6707 Results for: "SDG 3 – Gute Gesundheit und Wohlergehen"
  1. Published

    Cetuximab in metastatic colorectal cancer - Author' reply

    Folprecht, G. & Koehne, C-H., Apr 2010, In: The Lancet Oncology. 11, 4, p. 314 1 p.

    Research output: Contribution to journal › Letter › Contributed › peer-review

  2. Published

    Cetuximab and irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (AIO) is active and safe in the first-line treatment of metastatic colorectal cancer (mCRC) expressing the epidermal growth factor receptor (EGFR)

    Folprecht, G., Lutz, M. P., Schoeffski, P., Seufferlein, T., Nolting, A., Pollert, P. & Koehne, C., Oct 2005, In: European Journal of Cancer : EJC Supplements. 3, 2, p. 199-199 1 p.

    Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

  3. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C

    Müller, T., Buch, S., Berg, T., Hampe, J. & Stickel, F., 2011, In: Journal of hepatology. 55, 3, p. 732-733

    Research output: Contribution to journal › Research article › Contributed › peer-review

  4. Published

    Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases

    Folprecht, G. & Köhne, C. H., Mar 2008, In: Advances in Gastrointestinal Cancers. 6, 1, p. 13-14 2 p.

    Research output: Contribution to journal › Comment/Debate › Contributed › peer-review

  5. Published

    Completion of hepatitis c virus replication cycle in heterokaryons excludes dominant restriction factors in human non-liver and mouse liver cell lines

    Frentzen, A., Hueging, K., Bitzegeio, J., Friesland, M., Hoffmann, M., Lindemann, D., Zimmer, G., & 4 othersZielecki, F., Weber, F., Steinmann, E. & Pietschmann, T., 2011, In: Journal of hepatology. 54, Suppl 1, 40.

    Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

  6. Published

    Cancer cells evade ferroptosis: sex hormone-driven membrane-bound O-acyltransferase domain-containing 1 and 2 (MBOAT1/2) expression

    Belavgeni, A., Tonnus, W. & Linkermann, A., 8 Sept 2023, In: Signal Transduction and Targeted Therapy. 8 (2023), 1, 2 p., 336.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  7. Published

    Präkonzeptionelle Beratung bei Diabetes mellitus: Bereit fur die Schwangerschaft?

    Madej, D., Wimberger, P., Tsourdi, E. & Goeckenjan, M., 1 May 2021, In: Diabetes aktuell. 19, 3, p. 102-109 8 p.

    Research output: Contribution to journal › Research article › Contributed › peer-review

  8. Published

    Identifying the Effects of COVID-19 on Psychological Well-Being Through Unsupervised Clustering for Mixed Data

    Lingelbach, K., Gado, S., Janssen, D., Piechnik, D., Eichler, M., Knopf, D., Hentschel, L., & 3 othersSchuler, M., Sernatinger, D. & Peissner, M., 2022, Proceedings of 6th International Congress on Information and Communication Technology, ICICT 2021. Yang, X-S., Sherratt, S., Dey, N. & Joshi, A. (eds.). Springer Science and Business Media B.V., p. 883-895 13 p. (Lecture Notes in Networks and Systems, Vol. 235).

    Research output: Contribution to book/Conference proceedings/Anthology/Report › Conference contribution › Contributed › peer-review

  9. Published

    Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies

    Wobus, M. & Bornhäuser, M., 2023, In: Frontiers in oncology. 13, 1231467.

    Research output: Contribution to journal › Editorial (Lead article) › Contributed › peer-review

  10. Published

    Human immunodeficiency virus infection and the thyroid gland

    Heufelder, AE. & Hofbauer, LC., 1996, In: European journal of endocrinology.

    Research output: Contribution to journal › Research article › Contributed › peer-review

Previous 1...48 49 50 51 52 53 54 55 ...671 Next
Export list (max. 500):